BIOCYTICS AND EREMID GENOMIC SERVICES COLLABORATE ON RESEARCH STUDY FOR NOVEL SINGLE-CELL TRANSCRIPTOMICS IMMUNE-BASED CANCER CELL THERAPY

Summary

BioCytics engaged Eremid Genomic Services to perform single-cell transcriptomic sequencing on an autologous immune cell fraction for its immune-based cancer cell therapy program. This collaboration supports BioCytics' research efforts in developing novel cancer therapeutics.